The Effects of Monitoring and Feedback on Compliance

A two-group randomized experimental design was employed to assess the effects of monitoring and feedback on the compliance of 93 psychiatric outpatients treated with lithium. Compliance in both groups was measured using self-report, lithium level, appointment-keeping, and medication refill frequency. The experimental group was also monitored using a unique electronic device that records the time and day pills are removed. At the midpoint of the study, the experimental group received feedback about serum lithium levels and patterns of removing medications from the monitoring device while the control group received feedback about serum lithium levels only. The study demonstrated no sustained effect of the monitoring and feedback interventions on compliance.

[1]  A Amdisen,et al.  Serum Level Monitoring and Clinical Pharmacokinetics of Lithium , 1977, Clinical pharmacokinetics.

[2]  N. Kaplan,et al.  Two techniques to improve adherence to dietary sodium restriction in the treatment of hypertension. , 1982, Archives of internal medicine.

[3]  J. Fleiss.  Statistical methods for rates and proportions , 1974 .

[4]  P. Baastrup.  SUPPLEMENTARY INFORMATION ABOUT LITHIUM TREATMENT OF MANIC‐DEPRESSIVE DISORDERS , 1968, Acta psychiatrica Scandinavica. Supplementum.

[5]  P. Vestergaard,et al.  Patient attitudes towards lithium , 1983, Acta psychiatrica Scandinavica.

[6]  G. Fava,et al.  Hyperprolactinemia, distress, and hostility. , 1984, The American journal of psychiatry.

[7]  N. Fineberg,et al.  Influence of home monitoring on compliance with a reduced sodium intake diet. , 1984, Archives of internal medicine.

[8]  H. Toutenburg.  Fleiss, J. L.: Statistical Methods for Rates and Proportions. John Wiley & Sons, New York‐London‐Sydney‐Toronto 1973. XIII, 233 S. , 1974 .

[9]  R. D. Eney,et al.  Compliance of chronic asthmatics with oral administration of theophylline as measured by serum and salivary levels. , 1976, Pediatrics.

[10]  A. Lilienfeld,et al.  Studies in the epidemiology and preventability of rheumatic fever. IV. A quantitative determination of compliance in children on oral penicillin prophylaxis. , 1969, Pediatrics.

[11]  S. Cochran.  Preventing medical noncompliance in the outpatient treatment of bipolar affective disorders. , 1984, Journal of consulting and clinical psychology.

[12]  C. Connelly.  Compliance with outpatient lithium therapy. , 2009, Perspectives in psychiatric care.

[13]  L. Green,et al.  Concurrent and Predictive Validity of a Self-reported Measure of Medication Adherence , 1986, Medical care.

[14]  N. Azrin,et al.  Behavioral engineering: the use of response priming to improve prescribed self-medication. , 1969, Journal of applied behavior analysis.

[15]  D J Kupfer,et al.  Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Report of the NIMH Collaborative Study Group comparing lithium carbonate, imipramine, and a lithium carbonate-imipramine combination. , 1984, Archives of general psychiatry.

[16]  D. Roter.  Patient Participation in the Patient-Provider Interaction: The Effects of Patient Question Asking on the Quality of Interaction, Satisfaction and Compliance* , 1977, Health education monographs.

[17]  Alan E. Kazdin,et al.  Behavior modification in applied settings , 1975 .

[18]  L. Kreuger,et al.  Monitoring medication compliance: description of a new device. , 1987, The Journal of compliance in health care : JCHC.

[19]  M. Amdur.  Medication compliance in outpatient psychiatry. , 1979, Comprehensive psychiatry.

[20]  H. Pétursson.  Prediction of lithium response. , 1979, Comprehensive psychiatry.

[21]  I. Rosenstock.  Historical Origins of the Health Belief Model , 1974 .

[22]  H. Shamoon,et al.  Self-Monitoring of Capillary Blood Glucose: Changing the Performance of Individuals with Diabetes , 1985, Diabetes Care.

[23]  M. Keller.  Chronic and recurrent affective disorders: incidence, course, and influencing factors. , 1985, Advances in biochemical psychopharmacology.

[24]  J. A. Ramsay.  Participants in Noncompliance Research: Compliant or Noncompliant? , 1982, Medical care.

[25]  M. Lund,et al.  Serum Diphenylhydantoin (Phenytoin) in Ambulant Patients with Epilepsy , 1964, Epilepsia.

[26]  P. Grof,et al.  Lithium Prophylaxis in Recurrent Affective Disorders , 1970, British Journal of Psychiatry.

[27]  J. Kane.  Compliance Issues in Outpatient Treatment , 1985, Journal of clinical psychopharmacology.

[28]  J. Takala,et al.  Improving Compliance with Therapeutic Regimens in Hypertensive Patients in a Community Health Center , 1979, Circulation.

[29]  J. Nurnberger,et al.  Adherence to treatment regimen in a lithium carbonate clinic. , 1982, Archives of general psychiatry.

[30]  S. Kaplan,et al.  Expanding patient involvement in care. Effects on patient outcomes. , 1985, Annals of internal medicine.

[31]  P. Bech,et al.  LITHIUM MAINTENANCE TREATMENT OF MANIC‐MELANCHOLIC PATIENTS: ITS ROLE IN THE DAILY ROUTINE , 1976, Acta psychiatrica Scandinavica.

[32]  C. A. Nugent,et al.  Salt restriction in hypertensive patients. Comparison of advice, education, and group management. , 1984, Archives of internal medicine.

[33]  K. Dawson,et al.  Value of blood phenytoin estimation in management of childhood epilepsy. , 1971, Archives of disease in childhood.

[34]  A. Sherwin,et al.  Improved control of epilepsy by monitoring plasma ethosuximide. , 1973, Archives of Neurology.